Clinical Trials Logo

Clinical Trial Summary

The proposed study aims to test if Gunnar computer glasses provide any advantages, in comparison to no glasses, on the following aspects in computer-related office work:

- Any enhancement on visual performance of basic visual function, including visual acuity, contrast sensitivity, color discrimination, etc.

- Any enhancement on visual performance of typical office work, including reading, word-spelling check, number searching, or target identification.

- Any benefit in objective viewing comfort measured with viewing distance, blink frequency, post-viewing pupil size.

- Any benefit in subjective viewing comfort reflected on the questionnaire of viewing symptom survey.

- Any benefit in viewing comfort and visual performance with increased environmental ventilation or under strong glare.

- Any benefit in life quality from daily wearing (e.g., better comfort or sleep quality).


Clinical Trial Description

<Introduction>

When performing near work, one must focus at (accommodate) and point toward (converge) at a closer distance, and constantly re-focus the eyes in order to see small text and images with clarity. Sustaining such efforts can lead to eye fatigue and eye strain, among a host of vision problems. Most visual tasks on a screen also demand heightened visual concentration and this decreases blink rate. Combined with working in a heated or air-conditioned office environment, which leads to over-evaporation of tear film and lipid deficiency, irritation and dryness to the surface of the cornea are expected. Disruptive glare from excessive screen reflection and ambient lighting also deteriorates the image quality and heaps on viewing discomfort. With extensive screen viewing also exacerbate discomfort in people with existing vision problems like eye muscle imbalance, astigmatism, farsightedness and presbyopia. Since technology is almost unavoidable to modern life, preventions should be taken to lessen the total toll on the eyes and visual system. Gunnar computer glasses address the above issues by providing mild yellow tint anti-reflection coating aimed to shield the harmful blue light and lessen strong glare. The glasses also have a small amount of magnification (+0.5 D) to enhance acuity. The curved frame is designed to retain moisture and reduce dry eye symptoms. All these special characters are devised to enhance visual performance and minimize eye fatigue and visual discomfort in digital viewing. The current study aimed to validate the aforementioned benefits.

Gunnar over-the counter (OTC) computer glasses adopt yellow lenses to cut off the active short wavelength and lessen the bright glare, which often induces the detrimental effect caused by excessive illumination or intense scattered reflection. While the general benefit of glare reduction is well received, the benefit on visual performance has been inconclusive. Some studies reported significant enhancement in contrast sensitivity, but some failed to see any improvement on visual acuity and contrast sensitivity, even with color distortion. Without argument, tinted lenses reduce the transmittance of the visible spectrum and change the visible color to a certain degree. However, there has been report that a reduction of the retinal illumination level does not necessarily lead to reduced brightness; instead, the visual system automatically adjusts for the illumination discounting, possibly with the help of increased pupil size. In addition, with the decrement of blue lights arriving to the eyes, both scattered reflection and chromatic aberration are reduced. Together, it is reasonable to believe that the visual acuity, contrast sensitivity, and chromatic discrimination will not suffer and may, instead, benefit from the filter of yellow lenses. These basic visual functions may, in turn, lead to enhancement in general visual performance such as routine office work. These will be tested in the proposed study.

The current study tested if Gunnar's OTC computer glasses provide any advantages, in comparison to no glasses, on the following aspects in computer-related office work:

- Any enhancement on visual performance of basic visual function, including visual acuity, contrast sensitivity, color discrimination, etc.

- Any enhancement on visual performance of typical office work, including reading, word-spelling check, number searching, or target identification.

- Any benefit in preventing from dry eye by measuring the humidity outside and inside the frame (only in the visit with Gunnar glasses) and the tear film break-up time after viewing for a prolonged period of time.

- Any benefit in objective viewing comfort measured with viewing distance, blink frequency, post-viewing pupil size.

- Any benefit in subjective viewing comfort reflected on the questionnaire of viewing symptom survey.

- Any benefit in viewing comfort and visual performance with increased environmental ventilation.

- Any benefit in viewing comfort and visual performance with increased environmental under strong glare.

- Any benefit in life quality from daily wearing (e.g., viewing comfort, sleep quality or quantity due to the amount of stimulation from blue light)?

- Their willingness to purchase (select) the tested Gunnar OTC glasses, and the price willing to pay for.

<Study design>

Thirty-four subjects, age 18 to 42, were planned to be recruited. This sample size is based on a priori power analysis with 80% and a medium effect size at alpha equal to 0.05. Subjects will be stratified into 4 age groups. About equal number (8±1) of subjects should have been recruited for each group:

- 18-23 yr old

- 24-29 yr old

- 30-35 yr old

- 36-42 yr old

Each subject was scheduled for 3 visits: Visit 1 for screening and consenting, visit 2 for lab test after treatment 1, and visit 3 for lab test after treatment 2. Between visits was a adaptation period for the assigned treatment.

Visit 1: Screening visit

- Day 1, when a subject first joins the study

- Obtain informed consent and screening measurements (VA, contrast sensitivity, tear film break-up time as dry eye measurement, Dry eye questionnaire (OSDI), viewing symptom survey (VSS), history of dry eye and computer work behavior).

- At the end of the visit, half of the subjects were given a pair of Gunnar OTC glasses for adaptation for 3 - 7 days; the other half were given no treatment. All subjects were told to work in front of computer for at least 4 hour a day, with the assigned glasses if given.

Adaptation 1:

- Starting on Day 1, for 3 to 7 days, subject was asked to work in front of computers for at least 4 hours each day with assigned treatment 1.

Visit 2: Lab test for treatment 1

- On a day between day 4 and day 8 convenient to the subject, subject came to the lab with the assigned glasses condition.

- Baseline measurements will be taken, followed by a few visual tasks under 3 viewing conditions. Subject was asked to fill out the VSS, given a break, before tested on another round of tasks under a different viewing condition.

- The total testing time is about 70 minutes for each condition and about 4 hours to complete the visit.

- The lab testing procedure is described below.

- At the end of visit 2, treatment was alternated for another 3-7 days of adaptation.

Adaptation 2 with treatment 2:

- Starting on the day of Visit 2 after the test, subject adapt to the second treatment (with Gunnar glasses or without any glasses) for another 3 to 7 days.

Visit 3: Lab test for treatment 2

- The same procedure of Visit 2 was repeated.

- Subject was asked to rate their preference of wearing the Gunnar Glasses over no-glasses when performing computer tasks.

- After this visit, the study was completed for the subject.

Details of lab testing procedures:

- The study adopted a crossover design. Each subject went through three viewing conditions (control, bright light, strong ventilating) based on a Latin Square order.

1. In the control condition, the subject will perform all tasks under regular office lighting (500 lux) and the default lab ventilation condition.

2. In the bright light condition, the ambient light will be increased to 1500 lux.

3. In the strong ventilation condition, a ceiling fan will be positioned on top of the subject at the ceiling light location to increase the air flow.

Visual performance tasks:

- Baseline measurements (10 min): Upon arrival, subject was asked to fill out VSS and OSDI. Measurements of dry eye condition, pupil size, accommodation status, and blink rate were taken as baseline for the visit.

- Under viewing condition 1:

1. Visual tasks (60 minutes): Visual acuity, contrast sensitivity, color perception, visual search of numbers among a number matrix, low-contrast target search, text reading, and spelling check were performed by a fixed order.

2. Post-task measurements of dry eye measure (Tear break up time), pupil size, accommodation, and blink rate as well as VSS were taken.

- Break time of 5-10 minutes.

- Repeat the above procedures for the other two viewing conditions.

- Total time for one lab visit was about 4 hours. ;


Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02925884
Study type Interventional
Source Pacific University
Contact
Status Terminated
Phase N/A
Start date June 2013
Completion date September 2013

See also
  Status Clinical Trial Phase
Completed NCT05102409 - An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease Phase 2
Completed NCT06159569 - Performance and Tolerability of the Medical Device LACRIACT N/A
Completed NCT05027087 - The Effect of a Novel Blueberry Supplement on Dry Eye Disease Phase 3
Completed NCT04081610 - Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution Phase 1
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05825599 - PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms N/A
Completed NCT03418727 - Dry Eye Disease Study With Brimonidine Phase 2
Active, not recruiting NCT04425551 - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction N/A
Recruiting NCT04527887 - Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED) Phase 4
Not yet recruiting NCT06379685 - Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. Phase 1
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Completed NCT04553432 - Dry Eye OmniLenz Application of Omnigen Research Study Phase 4
Recruiting NCT04109170 - Dry Eye Evaluation System Based on Bioinformatics
Completed NCT04105842 - Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type N/A
Completed NCT05505292 - Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers Phase 4
Completed NCT04668131 - Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease N/A
Completed NCT06176651 - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Phase 4
Completed NCT02235259 - Efficacy and Safety of XG-104 for the Treatment of Dry Eye Phase 2
Not yet recruiting NCT02218827 - Topical Steroid Treatment For Dry Eye N/A
Completed NCT01959854 - Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye N/A